These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 15213178)

  • 1. Expression of a C terminally truncated form of pertussis toxin S1 subunit effectively induces protection against pertussis toxin following DNA-based immunization.
    Kamachi K; Arakawa Y
    Infect Immun; 2004 Jul; 72(7):4293-6. PubMed ID: 15213178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of safer pertussis DNA vaccine expressing non-toxic C180 polypeptide of pertussis toxin S1 subunit.
    Kamachi K; Arakawa Y
    Vaccine; 2007 Jan; 25(6):1000-6. PubMed ID: 17050047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA vaccine encoding pertussis toxin S1 subunit induces protection against Bordetella pertussis in mice.
    Kamachi K; Konda T; Arakawa Y
    Vaccine; 2003 Nov; 21(31):4609-15. PubMed ID: 14575775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of a pertussis toxin S1 fragment by inducible promoters in oral Streptococcus and the induction of immune responses during oral colonization in mice.
    Mallaley PP; Halperin SA; Morris A; MacMillan A; Lee SF
    Can J Microbiol; 2006 May; 52(5):436-44. PubMed ID: 16699568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parenteral immunization of mice with a genetically inactivated pertussis toxin DNA vaccine induces cell-mediated immunity and protection.
    Fry SR; Chen AY; Daggard G; Mukkur TKS
    J Med Microbiol; 2008 Jan; 57(Pt 1):28-35. PubMed ID: 18065664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of humoral immunity in response to immunization with recombinant Mycobacterium bovis BCG expressing the S1 subunit of Bordetella pertussis toxin.
    Medeiros MA; Armôa GR; Dellagostin OA; McIntosh D
    Can J Microbiol; 2005 Dec; 51(12):1015-20. PubMed ID: 16462859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal immunization with a genetically engineered pertussis toxin S1 fragment-cholera toxin subunit B chimeric protein.
    Lee SF; Halperin SA; Salloum DF; MacMillan A; Morris A
    Infect Immun; 2003 Apr; 71(4):2272-5. PubMed ID: 12654855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective immunogenicity of synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
    Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
    Dev Biol Stand; 1991; 73():111-20. PubMed ID: 1778305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically detoxified pertussis toxin (PT-9K/129G): implications for immunization and vaccines.
    Seubert A; D'Oro U; Scarselli M; Pizza M
    Expert Rev Vaccines; 2014 Oct; 13(10):1191-204. PubMed ID: 25183193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of different detoxification procedures on the residual pertussis toxin activities in vaccines.
    Yuen CT; Asokanathan C; Cook S; Lin N; Xing D
    Vaccine; 2016 Apr; 34(18):2129-34. PubMed ID: 26973066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between structure and biological and protective activities of pertussis toxin.
    Sato H; Sato Y
    Dev Biol Stand; 1991; 73():121-32. PubMed ID: 1723387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of an unmarked recombinant BCG expressing a pertussis antigen by auxotrophic complementation: protection against Bordetella pertussis challenge in neonates.
    Nascimento IP; Dias WO; Quintilio W; Hsu T; Jacobs WR; Leite LC
    Vaccine; 2009 Dec; 27(52):7346-51. PubMed ID: 19782111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations.
    Gracia A; Polewicz M; Halperin SA; Hancock RE; Potter AA; Babiuk LA; Gerdts V
    Vaccine; 2011 Feb; 29(8):1595-604. PubMed ID: 21215343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and characterization of genetically inactivated pertussis toxin.
    Brown DR; Keith JM; Sato H; Sato Y
    Dev Biol Stand; 1991; 73():63-73. PubMed ID: 1778335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular pertussis vaccine products.
    Cyr T; Menzies AJ; Calver J; Whitehouse LW
    Biologicals; 2001 Jun; 29(2):81-95. PubMed ID: 11580213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein.
    Price BM; Liner AL; Park S; Leppla SH; Mateczun A; Galloway DR
    Infect Immun; 2001 Jul; 69(7):4509-15. PubMed ID: 11401993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of plant-derived recombinant DTP subunit vaccine.
    Brodzik R; Spitsin S; Pogrebnyak N; Bandurska K; Portocarrero C; Andryszak K; Koprowski H; Golovkin M
    Vaccine; 2009 Jun; 27(28):3730-4. PubMed ID: 19464556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis.
    Garlapati S; Eng NF; Kiros TG; Kindrachuk J; Mutwiri GK; Hancock RE; Halperin SA; Potter AA; Babiuk LA; Gerdts V
    Vaccine; 2011 Sep; 29(38):6540-8. PubMed ID: 21771625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of the B oligomer to the protective activity of genetically attenuated pertussis toxin.
    Arciniega JL; Shahin RD; Burnette WN; Bartley TD; Whiteley DW; Mar VL; Burns DL
    Infect Immun; 1991 Oct; 59(10):3407-10. PubMed ID: 1894354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective antigens of Bordetella pertussis mouse-protection test against intracerebral and aerosol challenge of B. pertussis.
    Sato H; Sato Y
    Dev Biol Stand; 1985; 61():461-7. PubMed ID: 2872127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.